enGene Holdings Inc.
NASDAQ:ENGNBiotechnology
Healthcare
$1.72 -1.15%
-$0.02 today
- Market cap
- $115.27M
- Beta
- -0.29
- P/E (TTM)
- -1.8
- EPS (TTM)
- -$0.95
52W Low $1.40High $12.25
Volume 1.64M
Average 1.58M
ENGN EBITDA Margin
EBITDA as a percentage of revenue.
No reported EBITDA Margin figures are available to summarize.
EBITDA Margin history
Percent of revenue · from the income statement
No EBITDA Margin data reported for this period type.
EBITDA Margin vs competitors
How ENGN compares with its peers on the latest reported figures
ENGN Competitors Peer median
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | -2.4% | +29.0 pp | +11.8 pp | |
| LTM Mar 2026 | -75.1% | -6.9 pp | +343.8 pp | |
| LTM Mar 2026 | -1740.8% | -1565.2 pp | -167.5 pp | |
| LTM Mar 2026 | -2034.0% | -137.9 pp | — | |
| LTM Mar 2026 | -8478.5% | — | -15524.4 pp | |
| LTM Mar 2026 | -245200.0% | +208560.0 pp | -336389.4 pp | |
ENGNenGene Holdings Inc. | FY2025 | — | — | — |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| Peer median (excluding ENGN) | -1887.4% | -6.9 pp | -167.5 pp | |
Competitors are the stored peer set for ENGN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
USD
Metric | FY2021 Oct 2021 | FY2022 Oct 2022 | FY2023 Oct 2023 | FY2024 Oct 2024 | FY2025 Oct 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 12.46M | 15.47M | 16.46M | 38.32M | 94.48M |
| Selling, General & Admin | 3.16M | 3.26M | 8.47M | 23.98M | 28.69M |
| Operating Expenses | 15.87M | 19.43M | 26.06M | 62.3M | 123.17M |
| Depreciation & Amortization | 272K | 238K | 175K | 323K | 509K |
| EBITDA | (18.15M) | (22.78M) | (94.77M) | (52.04M) | (113.8M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (15.87M) | (19.43M) | (26.06M) | (62.3M) | (123.17M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 25K | 129K | 1.12M | 10.41M | 9.43M |
| Interest Expense | 5.02M | 1.42M | 4.95M | 2.8M | 2.99M |
| Other Income / Expenses | (7.57M) | (5.01M) | (73.84M) | 7.14M | 5.86M |
| Income Before Tax | (23.44M) | (24.44M) | (99.9M) | (55.16M) | (117.3M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 22K | 17K | (19K) | 0 |
| Net Income | (23.44M) | (24.46M) | (99.92M) | (55.14M) | (117.3M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (0.01) | 0.00 | (4.24) | (1.46) | (2.29) |
| EPS (Diluted) | (0.01) | 0.00 | (4.24) | (1.46) | (2.29) |
| Weighted Avg Shares | 15.81M | 15.81M | 23.56M | 44.64M | 51.12M |
| Weighted Avg Shares (Diluted) | 15.81M | 15.81M | 23.56M | 44.64M | 51.12M |
enGene Holdings Inc.
NASDAQ:ENGN
Intrinsic Alpha fair value
Locked
Current Price
$1.72
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.